CERE
Bank of America’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-338,455
| Closed | -$13.8M | – | 7465 |
|
|
2024
Q2 | $13.8M | Buy |
338,455
+117,548
| +53% | +$4.81M | ﹤0.01% | 2279 |
|
|
2024
Q1 | $9.34M | Buy |
220,907
+148,612
| +206% | +$6.28M | ﹤0.01% | 2596 |
|
|
2023
Q4 | $3.07M | Sell |
72,295
-69,220
| -49% | -$2.93M | ﹤0.01% | 3297 |
|
|
2023
Q3 | $3.09M | Buy |
141,515
+965
| +0.7% | +$21.1K | ﹤0.01% | 3210 |
|
|
2023
Q2 | $4.47M | Sell |
140,550
-134,826
| -49% | -$4.29M | ﹤0.01% | 2969 |
|
|
2023
Q1 | $6.72M | Buy |
275,376
+50,804
| +23% | +$1.24M | ﹤0.01% | 2758 |
|
|
2022
Q4 | $7.08M | Buy |
224,572
+112,212
| +100% | +$3.54M | ﹤0.01% | 2575 |
|
|
2022
Q3 | $3.18M | Buy |
112,360
+89,963
| +402% | +$2.54M | ﹤0.01% | 3262 |
|
|
2022
Q2 | $592K | Sell |
22,397
-44,793
| -67% | -$1.18M | ﹤0.01% | 4617 |
|
|
2022
Q1 | $2.35M | Sell |
67,190
-9,828
| -13% | -$344K | ﹤0.01% | 3844 |
|
|
2021
Q4 | $2.5M | Buy |
77,018
+41,363
| +116% | +$1.34M | ﹤0.01% | 3720 |
|
|
2021
Q3 | $1.05M | Buy |
35,655
+30,466
| +587% | +$899K | ﹤0.01% | 4297 |
|
|
2021
Q2 | $133K | Sell |
5,189
-9,817
| -65% | -$252K | ﹤0.01% | 5570 |
|
|
2021
Q1 | $206K | Buy |
15,006
+14,958
| +31,163% | +$205K | ﹤0.01% | 5367 |
|
|
2020
Q4 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 6242 |
|